Kestra Advisory Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Kestra Advisory Services’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.11M	Buy	26,384 +5,012	+23%	+$160K	﹤0.01%	1745
2026 Q1	$565K	Buy	21,372 +12,826	+150%	+$376K	﹤0.01%	2121
2025 Q4	$248K	Buy	+8,546	New	+$257K	﹤0.01%	2705
2025 Q2	–	Sell	-7,697	Closed	-$160K	–	2825
2025 Q1	$160K	Sell	7,697 -951	-11%	-$23.9K	﹤0.01%	2525
2024 Q4	$204K	Sell	8,648 -3,229	-27%	-$79.5K	﹤0.01%	2475
2024 Q3	$304K	Sell	11,877 -1,650	-12%	-$42K	﹤0.01%	2079
2024 Q2	$318K	Sell	13,527 -4,191	-24%	-$106K	﹤0.01%	2081
2024 Q1	$510K	Sell	17,718 -9,473	-35%	-$285K	﹤0.01%	1657
2023 Q4	$892K	Sell	27,191 -7,637	-22%	-$208K	0.01%	1188
2023 Q3	$970K	Buy	34,828 +4,491	+15%	+$147K	0.01%	1011
2023 Q2	$1.03M	Buy	30,337 +3,254	+12%	+$102K	0.01%	962
2023 Q1	$814K	Sell	27,083 -4,080	-13%	-$126K	0.01%	1044
2022 Q4	$880K	Sell	31,163 -4,593	-13%	-$146K	0.01%	1114
2022 Q3	$1.18M	Sell	35,756 -5,564	-13%	-$204K	0.01%	896
2022 Q2	$1.3M	Sell	41,320 -4,873	-11%	-$170K	0.01%	849
2022 Q1	$2.12M	Sell	46,193 -7,222	-14%	-$344K	0.02%	653
2021 Q4	$3.27M	Sell	53,415 -12,870	-19%	-$890K	0.03%	510
2021 Q3	$4.95M	Sell	66,285 -2,061	-3%	-$173K	0.05%	391
2021 Q2	$6.32M	Buy	68,346 +1,829	+3%	+$156K	0.07%	306
2021 Q1	$5.9M	Buy	66,517 +8,825	+15%	+$875K	0.07%	293
2020 Q4	$5.54M	Buy	57,692 +36,507	+172%	+$2.91M	0.06%	309
2020 Q3	$1.35M	Buy	+21,185	New	+$1.24M	0.03%	538

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Kestra Advisory Services's ARKG Position: Q2 2026 in Review

Kestra Advisory Services increased its ARK Genomic Revolution ETF (ARKG) stake by 23% in Q2 2026, buying an estimated $160K and bringing the position to 26,384 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1745.

Kestra Advisory Services first reported a position in ARKG in Q3 2020 and has held it in 22 quarters since. The position peaked at $6.32M in Q2 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Kestra Advisory Services held 26,384 shares of ARK Genomic Revolution ETF worth $1.11M as of Q2 2026.
Kestra Advisory Services bought 5,012 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $160K.
ARK Genomic Revolution ETF made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #1745 holding.
Kestra Advisory Services first reported a position in ARK Genomic Revolution ETF in Q3 2020 and has held it in 22 quarters since.
Kestra Advisory Services's ARK Genomic Revolution ETF position peaked at $6.32M in Q2 2021.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.